相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Surgeon experience in glioblastoma surgery of the elderly-a multicenter, retrospective cohort study
Johannes P. Poeppe et al.
JOURNAL OF NEURO-ONCOLOGY (2023)
Impact of maximal extent of resection on postoperative deficits, patient functioning, and survival within clinically important glioblastoma subgroups
Jasper K. W. Gerritsen et al.
NEURO-ONCOLOGY (2023)
SEER-based risk stratification system for patients with primary non-cirrhotic liver cancer
Runmin Cao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2023)
A novel risk signature for predicting brain metastasis in patients with lung adenocarcinoma
Yanyan Zhao et al.
NEURO-ONCOLOGY (2023)
Effectiveness of different treatment strategies in elderly patients with glioblastoma: An evidence map of randomized controlled trials
Wenbin Ma et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)
A prognostic nomogram for patients with newly diagnosed adult thalamic glioma in a surgical cohort
Xiaodong Niu et al.
NEURO-ONCOLOGY (2021)
Surgical strategies for older patients with glioblastoma
Tanyeri Barak et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2021)
Competing risk model to determine the prognostic factors and treatment strategies for elderly patients with glioblastoma
Zhuo-yi Liu et al.
SCIENTIFIC REPORTS (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Real-world evaluation of the impact of radiotherapy and chemotherapy in elderly patients with glioblastoma based on age and performance status
Karine A. Al Feghali et al.
NEURO-ONCOLOGY PRACTICE (2021)
Risks and Benefits of Glioblastoma Resection in Older Adults: A Retrospective Austrian Multicenter Study
Christoph Schwartz et al.
WORLD NEUROSURGERY (2020)
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma
Annette M. Molinaro et al.
JAMA ONCOLOGY (2020)
Surgical treatment and survival outcome of patients with adult thalamic glioma: a single institution experience of 8 years
Xiaodong Niu et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Survival Risk Prediction Models of Gliomas Based on IDH and 1p/19q
Han Zou et al.
JOURNAL OF CANCER (2020)
Glioblastoma in Elderly Patients: Current Management and Future Perspectives
Giuseppe Minniti et al.
CANCERS (2019)
Metastasis from glioblastoma multiforme: a meta-analysis
Marcelo Lemos Vieira da Cunha et al.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
Optimal extent of resection for glioblastoma according to site, extension, and size: a population-based study in the temozolomide era
Yi-Jun Kim et al.
NEUROSURGICAL REVIEW (2019)
Performance of a nomogram for IDH-wild-type glioblastoma patient survival in an elderly cohort
Erica Shen et al.
NEURO-ONCOLOGY ADVANCES (2019)
An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival
Haley Gittleman et al.
NEURO-ONCOLOGY ADVANCES (2019)
Glioblastoma in elderly patients: solid conclusions built on shifting sand?
Antje Wick et al.
NEURO-ONCOLOGY (2018)
Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location
Michael Karremann et al.
NEURO-ONCOLOGY (2018)
Thalamic Glioblastoma: Clinical Presentation, Management Strategies, and Outcomes
Yoshua Esquenazi et al.
NEUROSURGERY (2018)
Nomogram: An analogue tool to deliver digital knowledge
Seo Young Park
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2018)
Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG)
German Reyes-Botero et al.
ONCOLOGIST (2018)
Prognostic Factors for the Survival Outcome of Bilateral Thalamic Glioma: An Integrated Survival Analysis
Xiaodong Niu et al.
WORLD NEUROSURGERY (2018)
Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base
Jiayi Huang et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
The Added Prognostic Value of Metabolic Tumor Size on FDG-PET at First Suspected Recurrence of Glioblastoma Multiforme
Gloria C. Chiang et al.
JOURNAL OF NEUROIMAGING (2017)
Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline
Erik P. Sulman et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
EPID-08. EPIDEMIOLOGY OF GERM CELL TUMORS IN THE CENTRAL NERVOUS SYSTEM
Haley Gittleman et al.
NEURO-ONCOLOGY (2017)
Treatment strategy and IDH status improve nomogram validity in newly diagnosed GBM patients
Wen Cheng et al.
NEURO-ONCOLOGY (2017)
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
James R. Perry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Treatment of Glioblastoma in Older Adults
Kelly Braun et al.
CURRENT ONCOLOGY REPORTS (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival
Ranjith Babu et al.
JOURNAL OF NEUROSURGERY (2016)
Association of the Extent of Resection With Survival in Glioblastoma A Systematic Review and Meta-analysis
Timothy J. Brown et al.
JAMA ONCOLOGY (2016)
Nomograms in oncology: more than meets the eye
Vinod P. Balachandran et al.
LANCET ONCOLOGY (2015)
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
Annika Malmstrom et al.
LANCET ONCOLOGY (2012)
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
Wolfgang Wick et al.
LANCET ONCOLOGY (2012)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
Thierry Gorlia et al.
LANCET ONCOLOGY (2008)